Source:http://linkedlifedata.com/resource/pubmed/id/19827033
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-10-19
|
pubmed:abstractText |
We have reported that benzene-1,2-, 1,3-, and 1,4-di-N-substituted carbamates (1-15) are characterized as the conformationally constrained inhibitors of acetylcholinesterase and mimic gauche, eclipsed, and anti-conformations of acetylcholine, respectively (J Biochem Mol Toxicol 2007;21:348-353). We further report the inhibition of butyrylcholinesterase by these inhibitors. Carbamates 1-15 are also characterized as the pseudosubstrate inhibitors of butyrylcholinesterase as in the acetylcholinesterase catalysis. Benzene-1,4-di-N-n-hexylcarbamate (12) and benzene-1,4-di-N-n-octylcarbamate (13) are the two most potent inhibitors of butyrylcholinesterase among inhibitors 1-15. These two para compounds, with the angle of 180 degrees between two C(benzene)--O bonds, mimic the preferable anti C--O/C--N conformers for the choline ethylene backbone of butyrylcholine during the butyrylcholinesterase catalysis. The second n-hexylcarbamyl or n-octylcarbamyl moiety of inhibitors 12 and 13 is proposed to bind tightly to the peripheral anionic site of butyrylcholinesterase from molecular modeling. Butyrylcholinesterase prefers para-carbamates to ortho- and meta-carbamates, whereas acetylcholinesterase prefers para- and meta-carbamates to ortho-carbamates. This result implies that the anionic site of butyrylcholinesterase is relatively smaller than that of acetylcholinesterase because meta-carbamates, which may bind to the anionic sites of both enzymes, are not potent inhibitors of butyrylcholinesterase.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholinesterase,
http://linkedlifedata.com/resource/pubmed/chemical/Benzene,
http://linkedlifedata.com/resource/pubmed/chemical/Butyrylcholinesterase,
http://linkedlifedata.com/resource/pubmed/chemical/Carbamates,
http://linkedlifedata.com/resource/pubmed/chemical/Cholinesterase Inhibitors
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1099-0461
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
303-8
|
pubmed:dateRevised |
2011-3-18
|
pubmed:meshHeading |
pubmed-meshheading:19827033-Acetylcholinesterase,
pubmed-meshheading:19827033-Benzene,
pubmed-meshheading:19827033-Binding Sites,
pubmed-meshheading:19827033-Butyrylcholinesterase,
pubmed-meshheading:19827033-Carbamates,
pubmed-meshheading:19827033-Cholinesterase Inhibitors,
pubmed-meshheading:19827033-Isomerism,
pubmed-meshheading:19827033-Kinetics,
pubmed-meshheading:19827033-Models, Chemical,
pubmed-meshheading:19827033-Molecular Conformation,
pubmed-meshheading:19827033-Molecular Structure,
pubmed-meshheading:19827033-Structure-Activity Relationship,
pubmed-meshheading:19827033-Substrate Specificity
|
pubmed:articleTitle |
Comparison of active sites of butyrylcholinesterase and acetylcholinesterase based on inhibition by geometric isomers of benzene-di-N-substituted carbamates.
|
pubmed:affiliation |
Department of Neurosurgery, Chung Shan Medical University Hospital, Taichung 402, Taiwan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|